Najam Amina, Abid Rameesha, Ali Hussain, Hafeez Hamza, Arif Amna, Ahmed Safia, Di Cerbo Alessandro, Ghazanfar Shakira
Biological Production Division, National Institute of Health, Islamabad 45500, Pakistan.
Department of Microbiology, Quaid-I-Azam University, Islamabad 44100, Pakistan.
Vet Med Int. 2024 May 18;2024:4451881. doi: 10.1155/2024/4451881. eCollection 2024.
In developing countries, it is imperative to implement cost-effective strategies for animal humoral response development in the production of antiserum. This study compared the effect of immunization regimens on the humoral immune response of New Zealand White (NZW) rabbits ( = 24) using cell culture rabies vaccine (CCRV) through intradermal (ID) and traditional intramuscular (IM) routes. The rabbits were divided into three experimental groups: (a) IPC-R2 with a two-site one-week regimen; (b) TRC-R3 with a two-site twenty-eight-day regimen; and (c) Alternate-R4 with a four-site one-week regimen. These regimens were then compared to the standard IM schedule of five doses of rabies vaccine administered at days 0, 3, 7, 14, and 28 in control group R-1. The results were evaluated at days 14 and 35 postvaccination using rabies-specific Platelia II™ ELISA kit method. The results showed a better response to the ID regimen than the IM route regarding immunogenicity and volume consumption of the vaccine. The three selected ID regimes showed significantly higher mean titer values than the control IM regimen group R-1 ( < 0.001). The study aims to explore simple immunization strategies to enhance the RV-specific antibody titers for immunization donor animals. This method would produce polyclonal antibodies and strengthen local production of polyclonal antibodies in Pakistan to deal with vaccine and rabies immunoglobulin (RIG) shortage, thus providing effective postexposure prophylaxis (PEP) for better control of rabies in developing countries.
在发展中国家,在抗血清生产中实施具有成本效益的动物体液免疫反应开发策略势在必行。本研究比较了免疫方案对24只新西兰白兔(NZW)体液免疫反应的影响,使用细胞培养狂犬病疫苗(CCRV)通过皮内(ID)和传统肌肉注射(IM)途径进行免疫。兔子被分为三个实验组:(a)IPC-R2,采用两点一周免疫方案;(b)TRC-R3,采用两点二十八天免疫方案;(c)Alternate-R4,采用四点一周免疫方案。然后将这些方案与对照组R-1在第0、3、7、14和28天接种五剂狂犬病疫苗的标准IM免疫程序进行比较。在接种疫苗后的第14天和第35天,使用狂犬病特异性Platelia II™ ELISA试剂盒方法评估结果。结果显示,在疫苗的免疫原性和用量方面,ID免疫方案的反应优于IM途径。三种选定的ID免疫方案的平均滴度值显著高于对照组IM免疫方案组R-1(<0.001)。该研究旨在探索简单的免疫策略,以提高免疫供体动物的RV特异性抗体滴度。这种方法将产生多克隆抗体,并加强巴基斯坦多克隆抗体的本地生产,以应对疫苗和狂犬病免疫球蛋白(RIG)短缺的问题,从而提供有效的暴露后预防(PEP),以便在发展中国家更好地控制狂犬病。